State-run Bharat Sanchar Nigam Ltd (BSNL) said that it has launched its much awaited third-generation (3G) services across 11 cities.

BSNL also said that the 3G services will permit users to experience enhanced communications such as rich voice, video and data services.

India's No. 4 mobile operator also said that it will expand 3G services to other regions in the country.

With a total investment of Rs 450 crores, ACT Television has launched its first interactive TV services (IPTV) in Bangalore, Karnataka.

ACT, which has now become the first company to introduce Interactive TV service in the city, also said that it will take its new service to other Indian cities such as Andhra Pradesh, Karnataka and Madhya Pradesh by the next 12 to 18 months.

The company said that Interactive TV is a system delivering content services to subscribers using Internet protocol through a broadband link in a closed network infrastructure.

Recent study showed that fampridine, developed by Acorda Therapeutics Inc (ACOR. O) can help people with multiple sclerosis by improving their walk.

Doctors at SSKM Hospital were successful in helping Pratima, a four-and-half-year-old girl to breathe comfortably again. She swallowed a bulb of 2mm diameter while playing outside her home 10 days back. The bulb got struck in her left bronchus - a branch of the windpipe.

Arunabha Sengupta, an associate professor at the ENT department of SSKM, said: "The bulb had got stuck in her left lung. Her condition was deteriorating fast and only surgery could save her. We had to make sure that the bulb did not break. We managed to pull it out by its filament."

Recent study revealed that combination of two drugs can help in fighting extensively drug-resistant tuberculosis (XDR-TB).

Researchers said that AstraZeneca's (AZN. L) MERREM I. V., also called meropenem, used together with clavulanate, sold by GlaxoSmithKline (GSK. L) in combination with amoxicillin as the drug Augmentin, killed laboratory-grown strains of TB.

Recent study revealed that person sitting on the window seat faces double risk of developing a deep vein thrombosis (DVT) as compared to those sitting on the aisle or in a middle seat. A DVT clot can cause death if it passes through a passenger's bloodstream to the lungs, causing pulmonary embolism.

Research team from Leiden University Medical Centre found that obese people have six times higher risk of developing a blood clot when seated by the window. Hence obese passengers should prefer to sit either in the middle or aisle seats.